Fecal transplantation for type 1 diabetes

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2200055492

Enrollment

Unknown

Registered

2022-01-10

Start date

2022-01-10

Completion date

Unknown

Last updated

2023-02-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

type 1 diabetes

Interventions

Experimental group:fecal bacteria transplantation

Eligibility

Sex/Gender

All

Age

3 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Clinically diagnosed as T1DM or latent autoimmune diabetes in adults; 2. Aged 3-70 years; 3. Depends on insulin therapy, HbA1c<16%; 4. Informed consent.

Exclusion criteria

Exclusion criteria: 1. Uncorrected diabetic ketoacidosis or diabetic hyperosmolar state; 2. Severe heart, liver, kidney and other organ dysfunction; 3. There are acute stress situations such as infection, gastrointestinal bleeding, cardiovascular and cerebrovascular diseases; 4. There is a serious organic disease of the digestive system; 5. Pregnancy; 6. Mental disorders.

Design outcomes

Primary

Measure	Time frame
C peptide;glycosylated hemoglobin;	—

Countries

China

Contacts

Public ContactLin Kun

The First Affiliated Hospital of Shantou University School of Medicine

jornbar@126.com+86 13556422916

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026